Orlando, Fla. – October 02, 2026 -- Northern Jet has achieved Stage 1 registration under the International Standard for Business Aircraft Operations (IS-BAO), a credential issued August 31, 2026 and valid through August 31, 2028.

Washington – October 02, 2026 -- Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) is presenting three new data sets on its monoclonal antibody imsidolimab at the European Academy of Dermatology and Venereology (EADV) Annual Meeting in Vienna, Austria, running September 30 through October 3, 2026.

Palma de Mallorca, Spain – October 02, 2026 -- Smartee Denti-Technology concluded its first large-scale academic summit held outside China on September 19, drawing nearly 300 orthodontic clinicians from 27 countries to Palma de Mallorca and unveiling two new clear-aligner product systems for international markets.

Delray Beach – October 02, 2026 -- The global emulsifiers market is projected to climb to USD 18.15 billion by 2031, up from USD 12.15 billion in 2026, expanding at a compound annual growth rate of 8.4%, according to MarketsandMarkets.

Lysaker, Norway – – October 02, 2026 -- Aker BP has named a new executive management team that will take effect on January 1, 2027, reorganizing leadership around the company's full value chain from exploration to production.

Geneva – October 02, 2026 -- The employee partnership owning Gunvor Group Ltd has voted to rename the company Centalion Group Ltd and relocate its corporate headquarters from Cyprus to Singapore, marking the next phase after a December 2025 management buyout.

Nottingham, England – October 02, 2026 -- Quotient Sciences and Copenhagen-based Acesion Pharma have launched a collaboration to apply AI-enhanced formulation development to Acesion's early-stage pipeline of small molecules targeting atrial fibrillation, a condition affecting an estimated 50-60 million people globally.

Kilmarnock – October 02, 2026 -- Copenhagen Infrastructure Partners (CIP) has taken a Financial Investment Decision for Kilmarnock South, a 350 MW/1,400 MWh lithium-ion battery energy storage system in south Ayrshire, Scotland, committing over EUR 270 million (GBP 232 million) through its fourth flagship fund, Copenhagen Infrastructure IV.

Hong Kong – – October 02, 2026 -- Ascletis Pharma Inc. (HKEX: 1672) presented preclinical data showing its ASC36_35FDC injectable combination drove a 24.8% body-weight reduction in a diet-induced obesity rat model on Day 14, outperforming two competitor co-formulations tested under identical dosing conditions.

The data were unveiled in a short oral discussion at the 62nd European Association for the Study of Diabetes (EASD) Annual Meeting, held September 28–October 2, 2026, in Milan, Italy.

London – October 02, 2026 -- Samfara has completed the acquisition of Chr. Olesen Synthesis, a Danish manufacturer of controlled-substance active pharmaceutical ingredients, marking the London-based life sciences investment firm's first deal. The transaction sees Samfara buy the business from Chr. Olesen and funds managed by Signet Healthcare Partners, with Chief Executive Thomas Moestrup co-investing alongside the new owner. Financial terms were not disclosed.